Cellino
Cellino is an autologous regenerative medicine company developing an AI-guided single-cell laser editing platform for cell-based therapies. The company has developed a scalable platform that automates and standardizes autologous stem cell production, accelerating the development of life-saving medicines for patients.
Last updated on
About Cellino
Founded
2017Estimated Revenue
$1M-$10MEmployees
51-250Funding / Mkt. Cap
$98MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
CambridgeState
MassachusettsCountry
United StatesCellino
Find your buyer within Cellino